Matthieu Texier
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 3
- Colorectal Cancer Treatments and Studies 2
-
- Lung Cancer Treatments and Mutations 8
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- Stéphane Champiat (7 shared papers)Caroline Robert (6 shared papers)Émilie Lanoy (4 shared papers)Jean‐Charles Soria (7 shared papers)Christine Mateus (4 shared papers)Émilie Routier (3 shared papers)C. Boutros (3 shared papers)Aurélien Marabelle (6 shared papers)
In The Last Decade
Matthieu Texier
31 papers receiving 1.7k citations
Matthieu Texier's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 1.2k
- Immunology 499
- Pulmonary and Respiratory Medicine 197
- Dermatology 51
- Genetics 47
Countries citing papers authored by Matthieu Texier
This map shows the geographic impact of Matthieu Texier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Texier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Texier more than expected).
Fields of papers citing papers by Matthieu Texier
This network shows the impact of papers produced by Matthieu Texier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Texier. The network helps show where Matthieu Texier may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthieu Texier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination Hit paper breakdown → | 2016 | 826 |
| 2 | Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab Hit paper breakdown → | 2015 | 513 |
| 3 | 2020 | 91 | |
| 4 | 2018 | 48 | |
| 5 | 2022 | 37 | |
| 6 | 2022 | 21 | |
| 7 | 1989 | 20 | |
| 8 | 2017 | 19 | |
| 9 | 2021 | 17 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2019 | 13 | |
| 13 | 2018 | 10 | |
| 14 | 2020 | 7 | |
| 15 | 2018 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2021 | 5 | |
| 20 | 2019 | 4 |
About Matthieu Texier
Matthieu Texier is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Otorhinolaryngology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (8 papers), Head and Neck Cancer Studies (3 papers), Cancer Genomics and Diagnostics (3 papers), CAR-T cell therapy research (3 papers), Testicular diseases and treatments (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (499 citations), Pulmonary and Respiratory Medicine (197 citations), Dermatology (51 citations) and Genetics (47 citations). Matthieu Texier has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Stéphane Champiat, Caroline Robert, Émilie Lanoy, Jean‐Charles Soria, Christine Mateus, Émilie Routier, C. Boutros, Aurélien Marabelle, Olivier Lambotte and C. Libenciuc. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Lung Cancer, European Urology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.